Welcome to our dedicated page for Wearable Devices SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20-F and Form 6-K filings. On Stock Titan’s WLDSW SEC filings page, investors can review these regulatory documents alongside AI-generated summaries that clarify the key points in each report.
The company’s Form 6-K current reports often include details of capital-raising transactions, such as registered direct offerings of ordinary shares, pre-funded warrants, and ordinary warrants, as well as warrant inducement agreements. These filings typically describe purchase agreements, placement agency agreements, exercise prices, and registration commitments related to new securities. Other 6-Ks incorporate press releases about patents, product developments, and clinical or commercial milestones, making them an important source for understanding material events.
Wearable Devices also uses its SEC filings to file financial statements and management’s discussion and analysis for interim periods, and to update information about equity incentive plans and share reserves. Many of these reports are expressly incorporated by reference into existing registration statements on Form F-3 and Form S-8, which are also identified in the filings.
On this page, Stock Titan provides real-time access to new WLDSW filings from EDGAR, along with AI-powered explanations that break down complex legal and financial language into more accessible summaries. Users can quickly locate filings that relate to warrant terms, equity offerings, incentive plans, and other corporate actions, and can explore how these disclosures fit into the company’s broader strategy in AI-powered neural input wearables. This resource helps investors and researchers interpret the regulatory record of Wearable Devices Ltd. without reading every filing in full.
Wearable Devices Ltd. has launched ai6 Labs, a neural AI ecosystem designed to bridge human intent with digital reality using non-invasive Electromyography and its Mudra technology. The platform links foundational research, product commercialization, and rapid AI experimentation into a closed-loop system intended to accelerate innovation in touchless, intent-driven human–machine interaction.
The company positions ai6 Labs as a three-pillar ecosystem that turns biological signals into digital commands in a faster and more scalable way. Management describes this as an inflection point for AI wearables, extended reality gesture control, and non-invasive brain–computer interfaces, supporting its broader neural input product strategy.
Wearable Devices Ltd. appointed Kobbi Nir as an independent director to its Board of Directors. He is classified as a Class II director and is expected to be submitted for re-appointment at the company’s 2027 Annual General Meeting.
Mr. Nir will serve on the Board’s audit committee and compensation committee, bringing experience as CFO and deputy CEO of Moodify Ltd. and prior senior finance and board roles. He replaces Yaacov Goldman, who stepped down from the Board effective January 31, 2026, with the company stating his resignation was not due to any disagreement over operations, policies, or practices.
Wearable Devices Ltd., a foreign private issuer, submitted a Form 6-K to furnish the Notice of Meeting, Proxy Statement and Proxy Card for its Annual and Special General Meeting of Shareholders scheduled for October 24, 2025. Only shareholders of record holding ordinary shares at the close of business on September 26, 2024 are entitled to receive notice of, and vote at, the meeting in person or by proxy. The Form 6-K and its exhibit are also incorporated by reference into the company’s existing registration statements on Form S-8 and Form F-3.
Wearable Devices Ltd. entered a Securities Purchase Agreement with a single institutional investor for a combined equity and warrant financing. The company is selling 440,000 ordinary shares at $4.00 per share and pre-funded warrants for up to 560,000 ordinary shares at $3.9999 each in a registered direct offering. Each pre-funded warrant is immediately exercisable for one ordinary share at an exercise price of $0.0001, subject to a 9.99% beneficial ownership cap.
In a concurrent private placement, the investor will receive ordinary warrants to purchase up to 1,000,000 ordinary shares, exercisable immediately at $4.00 per share and expiring five years after issuance. The company engaged A.G.P./Alliance Global Partners as exclusive placement agent, agreeing to pay a 7.0% placement fee and a 1.0% management fee on aggregate gross proceeds, plus up to $65,000 for expenses. A related press release describes the transaction as a $4 million registered direct offering and concurrent private placement.
Wearable Devices Ltd. reported that it has secured a U.S. patent for a voice and gesture control technology aimed at AI-enabled wearables. The company announced the patent in a press release dated
Wearable Devices Ltd. filed a Form S-8 to register securities under its 2024 Global Equity Incentive Plan, incorporating the plan by reference to a prior Form 6-K filed on
Wearable Devices Ltd. reports that its board approved a significant increase in the ordinary shares reserved for its 2024 Global Equity Incentive Plan, adding 653,760 shares and raising the reserve from 141,492 to 795,252. This expands the pool available for future equity-based compensation grants.
The company also furnishes unaudited interim condensed consolidated financial statements and management’s discussion and analysis for the six months ended June 30, 2025, together with a press release on its first-half 2025 financial results. The report is incorporated by reference into existing Form S-8 and Form F-3 registration statements.
Armistice Capital, LLC and Steven Boyd report a shared beneficial interest in Wearable Devices Ltd. Together they hold 54,042 ordinary shares, representing 4.99% of the class. Armistice Capital, as investment manager to a Master Fund, exercises voting and investment power over those shares and Mr. Boyd, as managing member, may be deemed to beneficially own them. The filings state the reported shares are held with shared voting and dispositive power (no sole voting or dispositive power). The Master Fund is identified as the direct holder and retains the economic right to dividends or sale proceeds.
Wearable Devices Ltd., an Israel-incorporated company, filed a Form D to register a warrant-based offering under Rule 506(b). The stated total offering amount is $2,408,450 with $0 reported sold to date and $2,408,450 remaining. The filing lists a first sale date of 2025-08-06 and indicates the offering is not intended to last more than one year.
The filing clarifies that gross proceeds reflect the cash exercise of 1,661,000 existing warrants in a warrant inducement transaction and that a concurrent private placement issued 3,322,000 new warrants. Proceeds up to $5,680,620 from new warrant exercises are excluded from the offering amount. Minimum investment is reported as $0, sales commissions and finders' fees are $0, and the notice reports one investor so far. The issuer identified its industry as Other Technology, declined to disclose revenue/net asset ranges, and the Form D was signed by CEO Asher Dahan on 2025-08-14.
Wearable Devices Ltd. submitted a Form 6-K to furnish a press release dated August 11, 2025, announcing that it has secured a U.S. patent for what it describes as groundbreaking neural interface technology. This report mainly serves to officially provide that press release to investors and regulators.
The company also states that selected paragraphs and the forward-looking statements section of the press release are incorporated by reference into its existing registration statements on Form S-8 and Form F-3, meaning those registration documents now legally include the updated patent-related disclosure.
FAQ
What is the current stock price of Wearable Devices (WLDSW)?
